Publications by authors named "Jamie Vanhecker"

Claim this Profile
Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model.
Alexander J Lepak, Miao Zhao, Karen Marchillo, Jamie VanHecker, David R Andes

Antimicrob Agents Chemother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
Alexander J Lepak, Miao Zhao, Karen Marchillo, Jamie VanHecker, David R Andes

Antimicrob Agents Chemother· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against in an Model of Invasive Pulmonary Aspergillosis.
Miao Zhao, Alexander J Lepak, Karen Marchillo, Jamie Vanhecker, Hiram Sanchez

Antimicrob Agents Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model.
Miao Zhao, Alexander J Lepak, Karen Marchillo, Jamie VanHecker, David R Andes

Antimicrob Agents Chemother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.
Miao Zhao, Alexander J Lepak, Brian VanScoy, Justin C Bader, Karen Marchillo, Jamie Vanhecker

Antimicrob Agents Chemother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model.
Miao Zhao, Alexander J Lepak, Karen Marchillo, Jamie VanHecker, David R Andes

Antimicrob Agents Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model.
Alexander J Lepak, Miao Zhao, Karen Marchillo, Jamie VanHecker, David R Andes

Antimicrob Agents Chemother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.
Alexander J Lepak, Ajit Parhi, Michaela Madison, Karen Marchillo, Jamie VanHecker

Antimicrob Agents Chemother· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus.
Alexander J Lepak, Karen Marchillo, Jamie Vanhecker, David R Andes

Antimicrob Agents Chemother· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates.
Alexander J Lepak, Karen Marchillo, Jamie VanHecker, David R Andes

Antimicrob Agents Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model.
Alexander J Lepak, Karen Marchillo, Jamie VanHecker, Daniel Diekema, David R Andes

Antimicrob Agents Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis